<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04745338</url>
  </required_header>
  <id_info>
    <org_study_id>ECVAPP</org_study_id>
    <nct_id>NCT04745338</nct_id>
  </id_info>
  <brief_title>Effect Of Cryolipolysis On Visceral Adiposity Index In Polycystic Ovarian Syndrome Patients</brief_title>
  <official_title>Effect Of Cryolipolysis On Visceral Adiposity Index In Polycystic Ovarian Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study will be carried to investigate the effect of cryolipolysis on visceral adiposity&#xD;
      index in pco women randomized controlled trial&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be carried out on sixty females with polycystic ovarian syndrome (PCOS) who&#xD;
      were selected from the Outpatient Clinic of Gynecology at Qasr Al Aini University Hospital.&#xD;
      Their age ranged from 17-28 years, body mass index was 25-30 Kg/m2. They experienced&#xD;
      hyperandrogenism, hyperinsulinemia and amenorrhea not less than 6 months.&#xD;
&#xD;
      PCOS females will be randomly assigned into two equal groups: group (A) (control group)&#xD;
      consisted of 30 women who received low caloric diet (1200 Cal/day) and group (B) (study&#xD;
      group) consisted of 30 women who received the same diet regime and cryolipolysis&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visceral adiposity index</measure>
    <time_frame>3 months</time_frame>
    <description>indicator of adipose tissue distribution</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>up to 3 months</time_frame>
    <description>anthropometric measurement by kilogram (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>waist circumference</measure>
    <time_frame>up to 3 months</time_frame>
    <description>anthropometric measurement by centimeter (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>high density lipoprotein</measure>
    <time_frame>up to 3 months</time_frame>
    <description>blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum triglyceride level</measure>
    <time_frame>up to 3months</time_frame>
    <description>blood test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>low caloric diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>low caloric diet (1200cal/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cryolipolysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cryolipolysis 3 sessions one session every 6 weeks by 3max cool shaping device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3max cool shaping device</intervention_name>
    <description>cryolipolysis sessions are applied on abdomen area each session for 40 min. each</description>
    <arm_group_label>cryolipolysis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low calolric diet</intervention_name>
    <description>low caloric diet (1200cal/day)</description>
    <arm_group_label>cryolipolysis</arm_group_label>
    <arm_group_label>low caloric diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ranges from 20-28 years, body mass index ranges 25-30 Kg/m2. They have pco&#xD;
             syndrome .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetic patients.&#xD;
&#xD;
          -  Women with BMI&gt;30&#xD;
&#xD;
          -  Women having circulatory dysfunction.&#xD;
&#xD;
          -  Women with respiratory or cardiac disease&#xD;
&#xD;
          -  liver disease.&#xD;
&#xD;
          -  Skin disease .&#xD;
&#xD;
          -  Previous abdominal or uterine surgery&#xD;
&#xD;
          -  Physical impairment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>it is carried on women with dysfunction in ovaries</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fahema me okiel, phd</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>amal mo youssef, phd</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>miral mo saleh, md</last_name>
    <phone>01200678845</phone>
    <phone_ext>+012</phone_ext>
    <email>marmooramido@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>14788</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>miral s mohamed, md</last_name>
      <phone>01200678845</phone>
      <phone_ext>+012</phone_ext>
      <email>marmooramido@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Miral Saleh Mohamed</investigator_full_name>
    <investigator_title>ASSISTANT LECTURER</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

